Investigators sought to determine the effect of “Smart PSA” guidelines on screening behavior and biopsy outcomes among Black men.

CINCINNATI, March 19, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (ONCO), (“Onconetix” or the “Company”), (formerly Blue Water Biotech, Inc. (BWV)), a cancer ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...

Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

For men, a new urine test is improving prostate cancer detection. Men know about the PSA test but there's another test, the "mi-prostate score" or MIPS. It's been available since 2013. It combines PSA ...

For asymptomatic people without known risks, the downsides and uncertainties of multi-cancer early detection testing could ...

A new long-term study published in the New England Journal of Medicine followed 160,000 men for over two decades to examine the real impact of prostate cancer screening. While screening slightly ...

Source: Getty Images Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection. Serum PSA testing is not specific to prostate cancer, and ...